Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA
Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer's treatments? And should lawyers be allowed to use thesauruses? All that and more on the new episode of "The…
Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck’s lawsuit against the federal government and why the company believes drug pricing negotiation is “tantamount to extortion.” We also discuss the health effects of Canadian wildfires, the highlights of the year’s biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer’s.
What's Your Reaction?
